Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18111 | 503 | 25.0 | 70% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2241 | 4271 | GRANULOCYTIC SARCOMA//CHLOROMA//TUMOR LYSIS SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TUMOR LYSIS SYNDROME | Author keyword | 183 | 65% | 34% | 173 |
| 2 | RASBURICASE | Author keyword | 126 | 80% | 16% | 79 |
| 3 | ACUTE TUMOR LYSIS SYNDROME | Author keyword | 24 | 91% | 2% | 10 |
| 4 | SPONTANEOUS TUMOR LYSIS SYNDROME | Author keyword | 20 | 100% | 2% | 9 |
| 5 | RECOMBINANT URATE OXIDASE | Author keyword | 15 | 88% | 1% | 7 |
| 6 | TUMOR LYSIS SYNDROME TLS | Author keyword | 15 | 88% | 1% | 7 |
| 7 | TUMOR LYSIS | Author keyword | 14 | 53% | 4% | 18 |
| 8 | URATE OXIDASE | Author keyword | 6 | 24% | 4% | 20 |
| 9 | ACUTE TUMOUR LYSIS SYNDROME | Author keyword | 3 | 60% | 1% | 3 |
| 10 | METABOLIC EMERGENCIES | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TUMOR LYSIS SYNDROME | 183 | 65% | 34% | 173 | Search TUMOR+LYSIS+SYNDROME | Search TUMOR+LYSIS+SYNDROME |
| 2 | RASBURICASE | 126 | 80% | 16% | 79 | Search RASBURICASE | Search RASBURICASE |
| 3 | ACUTE TUMOR LYSIS SYNDROME | 24 | 91% | 2% | 10 | Search ACUTE+TUMOR+LYSIS+SYNDROME | Search ACUTE+TUMOR+LYSIS+SYNDROME |
| 4 | SPONTANEOUS TUMOR LYSIS SYNDROME | 20 | 100% | 2% | 9 | Search SPONTANEOUS+TUMOR+LYSIS+SYNDROME | Search SPONTANEOUS+TUMOR+LYSIS+SYNDROME |
| 5 | RECOMBINANT URATE OXIDASE | 15 | 88% | 1% | 7 | Search RECOMBINANT+URATE+OXIDASE | Search RECOMBINANT+URATE+OXIDASE |
| 6 | TUMOR LYSIS SYNDROME TLS | 15 | 88% | 1% | 7 | Search TUMOR+LYSIS+SYNDROME+TLS | Search TUMOR+LYSIS+SYNDROME+TLS |
| 7 | TUMOR LYSIS | 14 | 53% | 4% | 18 | Search TUMOR+LYSIS | Search TUMOR+LYSIS |
| 8 | URATE OXIDASE | 6 | 24% | 4% | 20 | Search URATE+OXIDASE | Search URATE+OXIDASE |
| 9 | ACUTE TUMOUR LYSIS SYNDROME | 3 | 60% | 1% | 3 | Search ACUTE+TUMOUR+LYSIS+SYNDROME | Search ACUTE+TUMOUR+LYSIS+SYNDROME |
| 10 | METABOLIC EMERGENCIES | 2 | 67% | 0% | 2 | Search METABOLIC+EMERGENCIES | Search METABOLIC+EMERGENCIES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RECOMBINANT URATE OXIDASE | 94 | 72% | 15% | 73 |
| 2 | MALIGNANCY ASSOCIATED HYPERURICEMIA | 76 | 93% | 6% | 28 |
| 3 | COMPASSIONATE USE TRIAL | 48 | 91% | 4% | 20 |
| 4 | SYNDROME COMPLICATING TREATMENT | 26 | 100% | 2% | 11 |
| 5 | TUMOR LYSIS SYNDROME | 22 | 26% | 15% | 73 |
| 6 | RASBURICASE | 15 | 43% | 5% | 26 |
| 7 | REDUCED DOSE RASBURICASE | 14 | 100% | 1% | 7 |
| 8 | ASPERGILLUS FLAVUS URICASE | 9 | 83% | 1% | 5 |
| 9 | XANTHINE NEPHROPATHY | 8 | 100% | 1% | 5 |
| 10 | URIC ACID NEPHROPATHY | 7 | 53% | 2% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Guidelines for the management of pediatric and adult tumor lysis syndrome: An evidence-based review | 2008 | 146 | 36 | 94% |
| The Tumor Lysis Syndrome | 2011 | 76 | 35 | 51% |
| Tumour lysis syndrome: new therapeutic strategies and classification | 2004 | 202 | 24 | 92% |
| Rasburicase in Tumor Lysis Syndrome of the Adult: A Systematic Review and Meta-analysis | 2013 | 9 | 28 | 86% |
| Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome | 2004 | 130 | 57 | 89% |
| Acute tumor lysis syndrome in solid tumors - a case report and review of the literature | 2003 | 69 | 37 | 97% |
| An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome | 2010 | 22 | 58 | 62% |
| Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies | 2012 | 4 | 29 | 97% |
| The management of tumor lysis syndrome | 2006 | 35 | 57 | 79% |
| The clinical management of tumour lysis syndrome in haematological malignancies | 2011 | 7 | 41 | 83% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANAL QUAL CONTROL UNIT | 1 | 100% | 0.4% | 2 |
| 2 | GUNDERSEN CLIN | 1 | 50% | 0.2% | 1 |
| 3 | HLTH SCI PHARMACOL THER EUT | 1 | 50% | 0.2% | 1 |
| 4 | MED CRIT CARE NEPHROL | 1 | 50% | 0.2% | 1 |
| 5 | MED SERV INFECT DIS UNIT | 1 | 50% | 0.2% | 1 |
| 6 | USF NEPHROL HYPERTENS | 1 | 50% | 0.2% | 1 |
| 7 | PEDIAT HEMATOL BLOOD MARROW TRANSPLANTAT | 1 | 29% | 0.4% | 2 |
| 8 | 1275 YORK AVE | 0 | 33% | 0.2% | 1 |
| 9 | EMERGENCY MEDSEATTLE CHILDRENS HOSP | 0 | 33% | 0.2% | 1 |
| 10 | INT ANALYT SCI | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000187782 | LEUKOSTASIS//HYPERLEUKOCYTOSIS//LEUCOSTASIS |
| 2 | 0.0000155994 | URICASE//UNIT ANALYT PROBES PROT BIOTECHNOLEDUC MINIST//ALLANTOIN |
| 3 | 0.0000123465 | RENAL LYMPHOMA//PRIMARY RENAL LYMPHOMA//PARANEOPLASTIC NEPHROTIC SYNDROME |
| 4 | 0.0000100058 | LYMPHOBLASTIC LYMPHOMA//BURKITTS LYMPHOMA//BURKITT LYMPHOMA |
| 5 | 0.0000088129 | MEDIASTINAL MASS//CHAMBERLAIN PROCEDURE//MEDIASTINAL MASS SYNDROME |
| 6 | 0.0000072806 | NEUTROPENIA RECOVERY//TRATAMENTO INTENS//CRITICALLY ILL CANCER PATIENTS |
| 7 | 0.0000050468 | REFEEDING SYNDROME//HYPOPHOSPHATEMIA//HYPOPHOSPHATAEMIA |
| 8 | 0.0000050343 | APRT DEFICIENCY//ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY//2 8 DIHYDROXYADENINE |
| 9 | 0.0000049086 | GOUT//TOPHI//FEBUXOSTAT |
| 10 | 0.0000045498 | RADIATION NEPHROPATHY//SCHISTOCYTE//RADIATION NEPHRITIS |